Contract V797D60711
Vyera Pharmaceuticals, Llc · Department Of Veterans Affairs · August 17, 2016
Vyera Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on August 17, 2016 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 26 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 14, 2022. If all options are exercised, the contract could reach $250,000.
Contract details
- PIID
- V797D60711
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 17, 2016
- Latest action
- October 14, 2022
Description
ADMIN - CORRECTS MODP00026
Modification timeline
-
October 14, 2022Mod P00027$0
-
September 30, 2022Mod P00026CONTRACT CANCELLATION DO TO FOLLOW-ON AWARD$0
-
August 3, 2022Mod P00025TEMPORARY CONTRACT EXTENSION$0
-
August 1, 2022Mod P00024PPR$0
-
March 15, 2022Mod P00023TEMPORARY CONTRACT EXTENSION$0
-
March 3, 2022Mod P00022ADMIN CHANGE$0
-
February 9, 2022Mod P00021ADMIN CHANGES$0
-
December 28, 2021Mod P00020PL2022 PRICING UPDATE$0
-
October 7, 2021Mod P00019PRODUCT ADDITIONS$0
-
August 13, 2021Mod P00018ADMINISTRATIVE CHANGE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D60711?
Contract V797D60711 is a federal contract awarded to Vyera Pharmaceuticals, Llc by Department Of Veterans Affairs on August 17, 2016 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 26 times since the base award.
Who won contract V797D60711?
Vyera Pharmaceuticals, Llc won contract V797D60711 from Department Of Veterans Affairs.
How much is contract V797D60711 worth?
Contract V797D60711 has obligated $0 to date but carries a potential ceiling of $250,000 if fully funded and all options are exercised.